Treatment of reflux oesophagitis.
D000464:Alginates / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001471:Barrett Esophagus / Q000188:drug therapy / Q000601:surgery; D001626:Bethanechol Compounds / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D002229:Carbenoxolone / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D003251:Constriction, Pathologic; D004294:Domperidone / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004942:Esophagitis, Peptic / Q000188:drug therapy* / Q000601:surgery / Q000628:therapy; D004943:Esophagogastric Junction / Q000502:physiology / Q000601:surgery; D005663:Furans / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use; D011899:Ranitidine; D017640:Silicates; D012824:Silicic Acid / Q000627:therapeutic use
D000464:Alginates; D000863:Antacids; D000897:Anti-Ulcer Agents; D001626:Bethanechol Compounds; D001639:Bicarbonates; D004338:Drug Combinations; D005663:Furans; D006635:Histamine H2 Antagonists; D017640:Silicates; D012824:Silicic Acid; D004294:Domperidone; D000536:Aluminum Hydroxide; C021080:pyrogastrone; D002927:Cimetidine; D011899:Ranitidine; D008787:Metoclopramide; D002229:Carbenoxolone